abemaciclib,lasofoxifene
eli lilly,pfizer,sermonix
['abemaciclib', 'lasofoxifene', 'breast', 'sermonix pharmaceuticals', 'sermonix ']
presenting : updated data from elaine-2 clinical trial of lasofoxifene in combination with abemaciclib in women with locally advanced or metastatic er+/her2- breast cancer and an esr1 mutation after progression on prior therapies #asco22 
At Sermonix Pharmaceuticals, we’re focused on developing innovative therapeutics to specifically treat ESR1- mutated metastatic breast and gynecological cancers